請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89498
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 袁小琀 | zh_TW |
dc.contributor.advisor | Hanna S. Yuan | en |
dc.contributor.author | 黃薰禾 | zh_TW |
dc.contributor.author | Hsun-Ho Huang | en |
dc.date.accessioned | 2023-09-07T17:16:02Z | - |
dc.date.available | 2023-11-09 | - |
dc.date.copyright | 2023-09-07 | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-08-01 | - |
dc.identifier.citation | 1. Zhang, L., Q. Lu, and C. Chang, Epigenetics in health and disease. Adv Exp Med Biol, 2020. 1253: p. 3-55.
2. Lin, C.C., et al., Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B. Nucleic Acids Res, 2020. 48(7): p. 3949-3961. 3. Reik, W., Stability and flexibility of epigenetic gene regulation in mammalian development. Nature, 2007. 447(7143): p. 425-32. 4. Smith, Z.D. and A. Meissner, DNA methylation: roles in mammalian development. Nat Rev Genet, 2013. 14(3): p. 204-20. 5. Mattei, A.L., N. Bailly, and A. Meissner, DNA methylation: a historical perspective. Trends Genet, 2022. 38(7): p. 676-707. 6. Golden, L.C., et al., Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes. Proc Natl Acad Sci U S A, 2019. 116(52): p. 26779-26787. 7. Zhou, S., et al., DNA demethylases remodel DNA methylation in rice gametes and zygote and are required for reproduction. Mol Plant, 2021. 14(9): p. 1569-1583. 8. Lan, Y., et al., Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation. Cell Rep, 2021. 37(10): p. 110095. 9. Zeng, Y. and T. Chen, DNA methylation reprogramming during mammalian development. Genes (Basel), 2019. 10(4). 10. Lee, J., et al., Preferable in vitro condition for maintaining faithful DNA methylation imprinting in mouse embryonic stem cells. Genes Cells, 2018. 23(3): p. 146-160. 11. Colwell, M.L., et al., Epigenetics and the exposome: DNA methylation as a proxy for health impacts of prenatal environmental exposures. Exposome, 2023. 3(1). 12. Hanson, H.E. and A.L. Liebl, The mutagenic consequences of DNA methylation within and across generations. Epigenomes, 2022. 6(4). 13. Poursafa, P., et al., DNA methylation: a potential mediator between air pollution and metabolic syndrome. Clin Epigenetics, 2022. 14(1): p. 82. 14. Beetch, M., et al., Dietary antioxidants remodel DNA methylation patterns in chronic disease. Br J Pharmacol, 2020. 177(6): p. 1382-1408. 15. Shi, Y., et al., Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther, 2022. 7(1): p. 200. 16. Vega-Benedetti, A.F., et al., DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer. Clin Epigenetics, 2023. 15(1): p. 98. 17. Chen, C., et al., DNA methylation: from cancer biology to clinical perspectives. Front Biosci (Landmark Ed), 2022. 27(12): p. 326. 18. Dhar, G.A., et al., DNA methylation and regulation of gene expression: guardian of our health. Nucleus (Calcutta), 2021. 64(3): p. 259-270. 19. Jin, B., Y. Li, and K.D. Robertson, DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer, 2011. 2(6): p. 607-17. 20. Jeltsch, A. and R.Z. Jurkowska, Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm. Nucleic Acids Res, 2016. 44(18): p. 8556-8575. 21. Ren, W., L. Gao, and J. Song, Structural basis of DNMT1 and DNMT3A-mediated DNA methylation. Genes (Basel), 2018. 9(12). 22. Yen, R.W., et al., Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res, 1992. 20(9): p. 2287-91. 23. Xie, S., et al., Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 1999. 236(1): p. 87-95. 24. Ramsahoye, B.H., et al., Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A, 2000. 97(10): p. 5237-42. 25. Pradhan, S., et al., Recombinant human DNA (cytosine-5) methyltransferase. I. expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem, 1999. 274(46): p. 33002-10. 26. Song, J., et al., Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science, 2011. 331(6020): p. 1036-40. 27. Hermann, A., R. Goyal, and A. Jeltsch, The DNMT1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J Biol Chem, 2004. 279(46): p. 48350-9. 28. Leonhardt, H., et al., A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell, 1992. 71(5): p. 865-73. 29. Okano, M., et al., DNA methyltransferases DNMT3A and DNMT3B are essential for de novo methylation and mammalian development. Cell, 1999. 99(3): p. 247-57. 30. Lauber, C., et al., Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients. Sci Rep, 2020. 10(1): p. 12761. 31. Park, D.J., et al., Characteristics of DNMT3A mutations in acute myeloid leukemia. Blood Res, 2020. 55(1): p. 17-26. 32. Kishtagari, A. and R.L. Levine, The role of somatic mutations in acute myeloid leukemia pathogenesis. Cold Spring Harb Perspect Med, 2021. 11(4). 33. Poondi Krishnan, V., et al., The aberrant epigenome of DNMT3B-mutated ICF1 patient iPSCs is amenable to correction, with the exception of a subset of regions with H3K4me3- and/or CTCF-based epigenetic memory. Genome Res, 2023. 33(2): p. 169-183. 34. Rasmi, Y., et al., The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. IBRO Neurosci Rep, 2023. 14: p. 28-37. 35. Pappalardo, X.G. and V. Barra, Losing DNA methylation at repetitive elements and breaking bad. Epigenetics Chromatin, 2021. 14(1): p. 25. 36. Norvil, A.B., et al., Effect of disease-associated germline mutations on structure function relationship of DNA methyltransferases. Genes (Basel), 2019. 10(5). 37. Chedin, F., M.R. Lieber, and C.L. Hsieh, The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by DNMT3A. Proc Natl Acad Sci U S A, 2002. 99(26): p. 16916-21. 38. Wienholz, B.L., et al., DNMT3L modulates significant and distinct flanking sequence preference for DNA methylation by DNMT3A and DNMT3B in vivo. PLoS Genet, 2010. 6(9): p. e1001106. 39. Suetake, I., et al., DNMT3L stimulates the DNA methylation activity of DNMT3A and DNMT3B through a direct interaction. J Biol Chem, 2004. 279(26): p. 27816-23. 40. Chen, Z.X., et al., Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem, 2005. 95(5): p. 902-17. 41. Aapola, U., et al., Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics, 2000. 65(3): p. 293-8. 42. Hata, K., et al., DNMT3L cooperates with the DNMT3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development, 2002. 129(8): p. 1983-93. 43. Guo, X., et al., Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. Nature, 2015. 517(7536): p. 640-4. 44. Denis, H., M.N. Ndlovu, and F. Fuks, Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep, 2011. 12(7): p. 647-56. 45. Dhayalan, A., et al., The DNMT3A PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J Biol Chem, 2010. 285(34): p. 26114-20. 46. Xu, T.H., et al., Structure of nucleosome-bound DNA methyltransferases DNMT3A and DNMT3B. Nature, 2020. 586(7827): p. 151-155. 47. Baubec, T., et al., Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature, 2015. 520(7546): p. 243-7. 48. Mensah, I.K., et al., Misregulation of the expression and activity of DNA methyltransferases in cancer. NAR Cancer, 2021. 3(4): p. zcab045. 49. Li, H. and M.A. Blanco, A catalytic dependent role for DNMT3B in tumor suppression. EBioMedicine, 2021. 65: p. 103237. 50. Liu, P., et al., Emerging role of different DNA methyltransferases in the pathogenesis of cancer. Front Pharmacol, 2022. 13: p. 958146. 51. Ilango, S., et al., Epigenetic alterations in cancer. Front Biosci (Landmark Ed), 2020. 25(6): p. 1058-1109. 52. Loaeza-Loaeza, J., et al., DNMT3B overexpression downregulates genes with CpG islands, common motifs, and transcription factor binding sites that interact with DNMT3B. Sci Rep, 2022. 12(1): p. 20839. 53. Zhao, S.G., et al., The DNA methylation landscape of advanced prostate cancer. Nat Genet, 2020. 52(8): p. 778-789. 54. Bernado, P., Effect of interdomain dynamics on the structure determination of modular proteins by small-angle scattering. Eur Biophys J, 2010. 39(5): p. 769-80. 55. Rambo, R.P. and J.A. Tainer, Characterizing flexible and intrinsically unstructured biological macromolecules by SAS using the Porod-Debye law. Biopolymers, 2011. 95(8): p. 559-71. 56. Petoukhov, M.V., et al., New developments in the program package for small-angle scattering data analysis. J Appl Crystallogr, 2012. 45(Pt 2): p. 342-350. 57. Jumper, J., et al., Highly accurate protein structure prediction with AlphaFold. Nature, 2021. 596(7873): p. 583-589. 58. Pettersen, E.F., et al., UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem, 2004. 25(13): p. 1605-12. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/89498 | - |
dc.description.abstract | 哺乳動物的DNA甲基化是一種在調節各種細胞事件中,發揮關鍵作用的表觀遺傳修飾機制。甲基化失調與多種人類疾病,包括癌症有關。在哺乳動物中,DNA甲基化是由三種DNA甲基轉移酶(DNMT1,DNMT3A和DNMT3B)實現的。近年來在轉移性去勢抗性前列腺癌(mCRPC)患者中,識別出兩種DNMT3B突變體(E515D和R545C),這些具有DNMT3B突變體的癌細胞中具有高甲基化的CpG位點。這兩種突變體不位於甲基轉移酶區域(MTase),而是位於ADD區域內。ADD區域可與組蛋白H3的N-端尾部未甲基化的K4(H3K4me0)相互作用。然而,目前尚不清楚這些突變是否會改變DNMT3B的結構與活性,或者它們是否會影響DNMT3B與組蛋白H3之間的相互作用。在本研究中,我們表達並純化了與DNMT3L(胺基酸178-379)結合的野生型和突變型DNMT3B (E515D和R545C)兩種長度的蛋白(胺基酸214-853和412-853),並測量了它們在存在或不存在40個氨基酸組蛋白H3肽的情況下的甲基轉移酶活性。在沒有或有H3肽的情況下,E515D的甲基轉移酶活性與野生型酶類似。然而,R545C突變體的甲基轉移酶活性,在存在H3肽(H3K4me0)的情況下比野生型DNMT3B活性更為增強。小角度X射線散射(SAXS)進一步顯示DNMT3B/3L複合物具有多種構象,包括「自抑制形式」或「活化形式」。相較於野生型,H3K4me0肽能夠將具有R545C突變的複合物更高百分比轉移到活化形式。總結來說,這些發現表明R545C突變增強了DNMT3B/3L複合物的甲基轉移酶活性,使其更容易通過與組蛋白H3尾部的相互作用而採取活性構象。因此,該研究闡明了R545C突變引起的DNMT3B在前列腺癌中異常高甲基化的潛在機制。 | zh_TW |
dc.description.abstract | Mammalian DNA methylation is an epigenetic modification mechanism that plays key roles in the regulation of various cellular events. Methylation dysregulations are associated with a wide spectrum of human diseases, including cancer. DNA methylation is achieved by three DNA methyltransferases in mammals, DNMT1, DNMT3A and DNMT3B. Two DNMT3B mutants (E515D and R545C) have been identified in the patients of metastatic castration-resistant prostate cancer (mCRPC) with hypermethylated CpG sites. These two mutations are not located in the methyltransferase domain (MTase) but located within the ADD domain, which is involved in the interaction with the histone H3 tail at unmethylated K4 (H3K4me0). However, it remains unknown if these mutations may change the structure and/or activity of DNMT3B, or it may affect the interactions between DNMT3B and histone H3 tail. In this study, we expressed and purified two constructs (residues 412-853 and 214-853) of wild-type and mutated DNMT3B (E515D and R545C) in complex with DNMT3L (residues 178-379) and measured their methyltransferase activities in the presence or absence of a 40-amino acid histone H3 peptide. In the absence or presence of the H3 peptides, the methyltransferase activities of E515D were similar to those of wild-type enzymes. However, the methyltransferase activities of R545C mutants were more strongly stimulated than those of wild-type DNMT3B by the H3 peptides. Small-angle X-ray scattering (SAXS) further shows that DNMT3B/3L complex was flexible with multiple conformations in autoinhibitory or activated forms. The H3 peptides, particularly H3K4me0/K36me3 peptide, can shift higher percentage of the complex with R545C mutation to the active conformation as compared to the wild-type enzyme. Overall, these findings demonstrate that the R545C mutation enhances the methyltransferase activity of DNMT3B/3L complex, making it more susceptible to adopting an active conformation through interactions with the histone H3 tail. This study thus illuminates the underlying mechanism for aberrant hypermethylation caused by the mutation of R545C in DNMT3B in prostate cancer. | en |
dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-07T17:16:02Z No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2023-09-07T17:16:02Z (GMT). No. of bitstreams: 0 | en |
dc.description.tableofcontents | Table of Contents
謝誌 i 中文摘要 ii Abstract iii Table of Contents iv List of Figures xi List of Tables xiii Chapter 1. Introduction 1 1.1 DNA methylation and its biological functions in epigenetics 1 1.2 DNA methylation by DNA methyltransferases (DNMTs) 2 1.3 Structures insights into DNMT3A and DNMT3B 4 1.4 Regulation of DNMTs by histone modifications 5 1.5 Prostate cancer-linked DNMT3B mutations 6 1.6 Specific aims 7 Chapter 2. Materials and methods 9 2.1 Plasmid constructs 9 2.2 Protein expression and purification 9 2.3 Circular dichroism (CD) spectroscopy 11 2.4 Measurement of DNMT3B activity 11 2.5 DNMT3B-DNA binding assays 13 2.6 Small angle X-ray scattering (SAXS) 14 2.7 Protein crystallization 14 Chapter 3. Results 16 3.1 Different constructs of wild-type and mutated DNMT3B were expressed and purified. 16 3.2 Mutations of E515D and R545C do not affect the overall folding of the DNMT3B/3L complex. 17 3.3 Mutation of R545C significantly enhances the methyltransferase activity of DNMT3B/3L complexes in the presence of H3 peptides. 17 3.4 Measurement of DNA-binding affinities of DNMT3B/3L complexes 19 3.5 Small angle X-ray scattering (SAXS) analysis of DNMT3B∆214/3L complex in the absence or presence of the histone H3 peptide 19 3.6 Crystallization screening of DNMT3BΔ412(465CAYQ468)/3L complex 22 Chapter 4. Discussion 23 Chapter 5. References 25 | - |
dc.language.iso | en | - |
dc.title | 前列腺癌相關之人類基因甲基轉移酶突變體的結構和生化研究 | zh_TW |
dc.title | Structural and biochemical investigation of the prostate cancer-related mutants of human DNA methyltransferase 3B | en |
dc.type | Thesis | - |
dc.date.schoolyear | 111-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 蕭傳鐙;詹迺立;曾秀如 | zh_TW |
dc.contributor.oralexamcommittee | Chwan-Deng Hsiao;Nei-Li Chan;Shiou-Ru Tzeng | en |
dc.subject.keyword | 表觀遺傳修飾機制,DNA 甲基化,DNA 甲基轉移酶,DNA 甲基化失調, | zh_TW |
dc.subject.keyword | Epigenetic modification,DNA methylation,DNA methyltransferase,Methylation dysregulations, | en |
dc.relation.page | 53 | - |
dc.identifier.doi | 10.6342/NTU202302549 | - |
dc.rights.note | 同意授權(全球公開) | - |
dc.date.accepted | 2023-08-02 | - |
dc.contributor.author-college | 醫學院 | - |
dc.contributor.author-dept | 生物化學暨分子生物學研究所 | - |
顯示於系所單位: | 生物化學暨分子生物學科研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-111-2.pdf | 4.44 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。